|
Home : About Gadolinium & Nephrogenic Systemic Fibrosis (NSF) About Gadolinium & Nephrogenic Systemic Fibrosis (NSF)
Nephrogenic Systemic Fibrosis (NSF) is a rare but potentially fatal degenerative disease of the skin and internal organs. First identified in 1997, it occurs only in a few patients -- those who have a serious kidney disease and have undergone magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA) tests. Many scientists believe NSF is caused by exposure to gadolinium, a chemical used as a dye in MRI/MRA tests. In fact, one study showed that more than 95 percent of NSF patients had been exposed to some type of gadolinium within three months of contracting the disease. In response, the FDA has already recommended that doctors avoid gadolinium, and MRI/MRAs in general, in patients with kidney failure. Researchers in the United States and Europe are working to determine whether the substance should be banned altogether.
LegalView's Nephrogenic Systemic Fibrosis site contains a wide range of information about NSF and Gadolinium. The following will help you find the information you need:
Gadolinium / Nephrogenic Systemic Fibrosis Background
Nephrogenic Systemic Fibrosis Treatment
Detailed Information on Nephrogenic Systemic Fibrosis
|




